Evidence map›Paper›PMID 28383180›Full record

ArticleChembiochem : a European journal of chemical biology2017

Two-Tier Screening Platform for Directed Evolution of Aminoacyl-tRNA Synthetases with Enhanced Stop Codon Suppression Efficiency.

Andrew E Owens, Katherine T Grasso, Christine A Ziegler, Rudi Fasan

Abstract read
In one paragraph

Article in Chembiochem : a European journal of chemical biology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Update of the Pyrrolysyl-tRNA Synthetase/tRNAJournal of bacteriology · 2023
    Review
  10. Article
  11. A Facile Platform to EngineerACS central science · 2022
    Article
  12. Article
  13. Impact of queuosine modification of endogenousFrontiers in molecular biosciences · 2022
    Article
  14. Article
  15. Directed Evolution of theInternational journal of molecular sciences · 2021
    Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Andrew E OwensDepartment of Chemistry, University of Rochester, Hutchinson Hall, Rochester, NY, 14627, USA.
Katherine T GrassoDepartment of Chemistry, University of Rochester, Hutchinson Hall, Rochester, NY, 14627, USA.
Christine A ZieglerDepartment of Chemistry, University of Rochester, Hutchinson Hall, Rochester, NY, 14627, USA.
Rudi FasanDepartment of Chemistry, University of Rochester, Hutchinson Hall, Rochester, NY, 14627, USA.ORCID 0000-0003-4636-9578
University of Rochester · US

Funding

Macrocyclic inhibitors of upstream protein activators of the Hedgehog pathwayR21CA187502 · NCI · UNIVERSITY OF ROCHESTER · PI FASAN, RUDI · 2014 to 2015
$367k
NCI NIH HHS R21 CA187502
6 · The paper itself

Abstract

Genetic code expansion through amber stop codon suppression provides a powerful tool for introducing non-proteinogenic functionalities into proteins for a broad range of applications. However, ribosomal incorporation of noncanonical amino acids (ncAAs) by means of engineered aminoacyl-tRNA synthetases (aaRSs) often proceeds with significantly reduced efficiency compared to sense codon translation. Here, we report the implementation of a versatile platform for the development of engineered aaRSs with enhanced efficiency in mediating ncAA incorporation by amber stop codon suppression. This system integrates a white/blue colony screen with a plate-based colorimetric assay, thereby combining high-throughput capabilities with reliable and quantitative measurement of aaRS-dependent ncAA incorporation efficiency. This two-tier functional screening system was successfully applied to obtain a pyrrolysyl-tRNA synthetase (PylRS) variant (CrtK-RS(4.1)) with significantly improved efficiency (+250-370 %) for mediating the incorporation of N

Indexed as

Protein BiosynthesisProtein Processing, Post-TranslationalAmino Acyl-tRNA SynthetasesArchaeal ProteinsBacterial ProteinsCloning, MolecularCodon, TerminatorDirected Molecular EvolutionEscherichia coliGenetic CodeHigh-Throughput Screening AssaysLysineMethanosarcina barkeriMutationProtein EngineeringRecombinant ProteinsAmino Acyl-tRNA SynthetasesArchaeal ProteinsBacterial ProteinsCodon, Terminatorepsilon-N-crotonyllysineLysinepyrrolysineRecombinant Proteinsaminoacyl-tRNA synthetasescrotonyl lysinedirected evolutionpyrrolysyl-tRNA synthetasesstop codon suppression

Identifiers

PMID28383180
PMCPMC5586079
OpenAlexW2604888580

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.